Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Dental Clinic, School of Paediatric Dentistry and Unit of Oral Medicine, University of Brescia, Piazzale Spedali Civili, Brescia, Italy.
Department of Molecular and Translational Medicine, Agrifood and Environmental Microbiology Platform (PiMiAA-AgroFood Lab), University of Brescia, Piazza del Mercato, Brescia, Italy.
J Indian Soc Pedod Prev Dent. 2020 Oct-Dec;38(4):387-392. doi: 10.4103/JISPPD.JISPPD_442_20.
Pits and fissures sealing and modulation of oral microbiota through probiotics are important preventive measures against dental decays. The aim of this study was to investigate the antibacterial activity of the Embrace™ WetBond™ Pit and Fissure Sealant (Pulpdent, USA) and UltraSeal XT® Hydro™ (Ultradent, USA) against selected oral bacteria and probiotics.
The antibacterial effect of both sealants was tested both through planktonic growth inhibition test - 96-well microtiter plates and agar disk diffusion assay containing light-cured Embrace™ and UltraSeal XT against Streptococcus mutans and two oral probiotics (Streptococcus salivarius and Lactobacillus reuteri).
Embrace™ showed a stronger and broad activity against all the bacterial strains tested (P < 0.05) in planktonic growth inhibition test even at its lowest dose (10 μl), with inhibition rates higher than 90% in all cases. UltraSeal XT Hydro™ showed a mild antibacterial activity against L. reuteri, with growth inhibition rates being 19% and 23% for 20 μl and 50 μl, respectively. Regarding agar disk diffusion test, both sealants showed exclusively an antibacterial activity by contact.
According to these findings, it is recommended to carefully plan the timing for the administration of different preventive interventions, such as oral probiotics assumption and sealant application, to maximize their specific effectiveness. We suggest prescribing oral probiotics first and putting off the Embrace™ sealant application to the end of probiotic treatment. On the contrary, it is possible to administer L. reuteri simultaneously with the application of UltraSeal XT® since it elicits a minimal antibacterial action against this oral probiotic.
窝沟封闭和通过益生菌调节口腔微生物群是预防龋齿的重要措施。本研究旨在研究 Embrace™ WetBond™窝沟封闭剂(美国 Pulpdent)和 UltraSeal XT® Hydro™(美国 Ultradent)对选定的口腔细菌和益生菌的抗菌活性。
通过浮游生长抑制试验-96 孔微量滴定板和琼脂盘扩散试验测试两种封闭剂的抗菌效果,其中含有光固化的 Embrace™和 UltraSeal XT 对抗变形链球菌和两种口腔益生菌(唾液链球菌和罗伊氏乳杆菌)。
在浮游生长抑制试验中,即使在最低剂量(10μl)下,Embrace™ 对所有测试的细菌菌株都表现出更强和更广泛的活性(P<0.05),抑制率在所有情况下均高于 90%。UltraSeal XT Hydro™对罗伊氏乳杆菌表现出温和的抗菌活性,20μl 和 50μl 的生长抑制率分别为 19%和 23%。关于琼脂盘扩散试验,两种封闭剂均通过接触显示出抗菌活性。
根据这些发现,建议仔细计划不同预防干预措施(如口服益生菌的使用和封闭剂的应用)的时间,以最大程度地发挥其特定效果。我们建议先开出口服益生菌,推迟 Embrace™ 封闭剂的应用,直到益生菌治疗结束。相反,由于 UltraSeal XT® 对这种口腔益生菌的抗菌作用最小,可以同时给予罗伊氏乳杆菌。